Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging.
Open accessThe DOI matches its OpenAlex record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Increased metabolic activity of fluorodeoxyglucose (FDG) in tissue is not only resulting of pathological uptake, but due to physiological uptake as well. This study aimed to determine the impacts of biological and procedural factors on FDG uptake of liver in whole body positron emission tomography/computed tomography (PET/CT) imaging. METHODS: Whole body fluorine-18 ((18)F) FDG PET/CT scans of 51 oncology patients have been reviewed. Maximum standardized uptake value (SUVmax) of lesion-free liver was quantified in each patient. Pearson correlation was performed to determine the association between the factors of age, body mass index (BMI), blood glucose level, FDG dose and incubation period and liver SUVmax. Multivariate regression analysis was established to determine the significant factors that best predicted the liver SUVmax. Then the subjects were dichotomised into four BMI groups. Analysis of variance (ANOVA) was established for mean difference of SUVmax of liver between those BMI groups. RESULTS: BMI and incubation period were significantly associated with liver SUVmax. These factors were accounted for 29.6% of the liver SUVmax variance. Statistically significant differences were observed in the mean SUVmax of liver among those BMI groups (P<0.05). CONCLUSIONS: BMI and incubation period are significant factors affecting physiological FDG uptake of liver. It would be recommended to employ different cut-off value for physiological liver SUVmax as a reference standard for different BMI of patients in PET/CT interpretation and use a standard protocol for incubation period of patient to reduce variation in physiological FDG uptake of liver in PET/CT study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed Central · doi:10.2967/jnumed.120.251744a · Cited by 1,172
Effects of Nonionic Intravenous Contrast Agents at PET/CT Imaging: Phantom and Canine Studies
Nakamoto, Y., Chin, B. B., Kraitchman, D. L., Lawler, L. P., Marshall, L. T., & Wahl, R. L. (2003) · Radiology · doi:10.1148/radiol.2273020299 · Cited by 111
Büsing, K. A., Schönberg, S. O., Brade, J., & Wasser, K. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.10.014 · Cited by 111 · cited 2×
“Other clinical and biological factors which were excluded from this study such as blood lipid profile (25), hepatic steatosis (43), diabetic status (44) and insulin (44) have been reported to have a significant effect on liver FDG uptake.”
BackgroundEffects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study
Kubota, K., Watanabe, H., Murata, Y., Yukihiro, M., Ito, K., Morooka, M., Minamimoto, R., Hori, A., & Shibuya, H. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.09.004 · Cited by 66 · cited 2×
“Our findings are contradicted with previous studies on the impact of blood glucose factor (24,41).”
BackgroundResultIncreasing Uptake Time in FDG-PET: Standardized Uptake Values in Normal Tissues at 1 versus 3 h
Chin, B. B., Green, E. D., Turkington, T. G., Hawk, T. C., & Coleman, R. E. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-008-0177-9 · Cited by 65
Shiono, S., Abiko, M., Okazaki, T., Chiba, M., Yabuki, H., & Sato, T. (2011) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2011.02.041 · Cited by 40 · cited 1×
“In PET/CT imaging, liver FDG uptake is commonly used as the reference standard for diagnosis (18,19), therapy assessment (20), prognosis (21) and quality control (22).”
MethodPET/CT mediastinal and liver FDG uptake: Effects of biological and procedural factors
Malladi, A., Viner, M., Jackson, T., Mercier, G., & Subramaniam, R. M. (2013) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/1754-9485.12015 · Cited by 35 · cited 6×
“FDG dose can affect the FDG uptake of liver, but it has only minimal effect compared with the other covariates, as it was applied within the range of injected doses for clinical studies (41).”
BackgroundMethodResultInfluentialMittal, B., Kuruva, M., Abrar, M., Kashyap, R., & Bhattacharya, A. (2012) · Indian Journal of Nuclear Medicine · doi:10.4103/0972-3919.108835 · Cited by 24
Cited by
Effects of blood glucose level on 18F-FDG uptake for PET/CT in normal organs: A systematic review
Sprinz, C., Altmayer, S., Zanon, M., Watte, G., Irion, K., Marchiori, E., & Hochhegger, B. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193140 · Cited by 82
Sprinz, C., Zanon, M., Altmayer, S., Watte, G., Irion, K., Marchiori, E., & Hochhegger, B. (2018) · Scientific Reports · doi:10.1038/s41598-018-20529-4 · Cited by 59
Impacts of time interval on 18F-FDG uptake for PET/CT in normal organs: A systematic review
Wang, R., Chen, H., & Fan, C. (2018) · Medicine · doi:10.1097/md.0000000000013122 · Cited by 15
Intrapatient variability of 18F-FDG uptake in normal tissues
Sayed, M. H. M., Abdelnaim, A. K., & Mohamadien, N. R. (2022) · Journal of Clinical Imaging Science · doi:10.25259/jcis_23_2022 · Cited by 2
Metadata
- Authors
- Mahmud, M. H., Nordin, A. J., Saad, F. F. A., & Azman, A. Z. F.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2015-10-01
- Volume
- 5
- Issue
- 5
- Pages
- 700-7
- OpenAlex
- W1950883301
- Cited by
- 25
- References
- 8
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging. https://app.cochat.ai/papers/10.3978/j.issn.2223-4292.2015.05.02
- The paper
- Mahmud, M. H., Nordin, A. J., Saad, F. F. A., & Azman, A. Z. F. (2015). Impacts of biological and procedural factors on semiquantification uptake value of liver in fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging. PubMed. https://doi.org/10.3978/j.issn.2223-4292.2015.05.02
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.